| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
DCGO
DocGo
|
Sep 30, 2026 | HOLD |
Buy
+587.2% avg upside
7 analysts
|
— | · | · |
|
CYRX
CryoPort
|
Sep 18, 2026 | BUY |
Strong Buy
-5.0% avg upside
15 analysts
|
$25.00
43.71% Upside
|
+2.1% | · |
|
OMDA
Omada Health, Inc.
|
Sep 11, 2026 | BUY |
Strong Buy
+36.0% avg upside
13 analysts
|
$35.00
68.14% Upside
|
+3.8% | · |
|
DH
Definitive Healthcare Corp
|
Sep 03, 2026 | HOLD |
Hold
+472.5% avg upside
19 analysts
|
— | -12.0% | · |
|
HQY
Healthequity
|
Aug 28, 2026 | BUY |
Strong Buy
+30.3% avg upside
20 analysts
|
$115.00
30.09% Upside
|
-7.3% | · |
|
MDLN
Medline
|
Aug 27, 2026 | BUY |
Strong Buy
+33.0% avg upside
27 analysts
|
$55.00
58.48% Upside
|
+0.8% | · |
|
VEEV
Veeva Systems
|
Aug 26, 2026 | BUY |
Buy
-3.4% avg upside
38 analysts
|
$340.00
19.14% Upside
|
+16.6% | · |
|
HCAT
Health Catalyst
|
Aug 19, 2026 | HOLD |
Hold
+214.1% avg upside
15 analysts
|
— | +4.7% | · |
|
LFST
Lifestance Health Group
|
Aug 19, 2026 | BUY |
Strong Buy
+1.9% avg upside
15 analysts
|
$18.00
49.63% Upside
|
-7.2% | · |
|
HSIC
Henry Schein
|
Aug 19, 2026 | BUY |
Buy
+10.1% avg upside
25 analysts
|
$110.00
30.94% Upside
|
-4.0% | · |
|
HIMS
Hims & Hers Health
|
Aug 11, 2026 | HOLD |
Buy
-3.4% avg upside
23 analysts
|
— | -3.9% | · |
|
CCSI
Consensus Cloud Solutions
|
Aug 10, 2026 | BUY |
Buy
-4.7% avg upside
6 analysts
|
$50.00
43.17% Upside
|
-6.9% | · |
|
ASTH
Astrana Health
|
Aug 09, 2026 | BUY |
Strong Buy
+57.6% avg upside
17 analysts
|
$65.00
82.78% Upside
|
-8.1% | · |
|
PRVA
Privia Health Group
|
Aug 09, 2026 | BUY |
Strong Buy
+62.2% avg upside
26 analysts
|
$35.00
77.82% Upside
|
-10.5% | · |
|
LFMD
LifeMD
|
Aug 06, 2026 | BUY |
Strong Buy
+250.0% avg upside
14 analysts
|
$9.00
210.35% Upside
|
-14.7% | · |
|
AMWL
American Well
|
Aug 05, 2026 | HOLD |
Hold
+19.3% avg upside
15 analysts
|
— | +3.1% | · |
|
BTSG
BrightSpring Health Services, Inc.
|
Aug 03, 2026 | BUY |
Strong Buy
+16.1% avg upside
20 analysts
|
$90.00
58.69% Upside
|
-6.4% | · |
|
TDOC
Teladoc
|
Jul 29, 2026 | HOLD |
Buy
+401.1% avg upside
38 analysts
|
— | -35.8% | · |
|
PGNY
Progyny
|
Jul 24, 2026 | BUY |
Strong Buy
+32.9% avg upside
15 analysts
|
$40.00
58.84% Upside
|
-18.2% | · |
|
EVH
Evolent Health
|
Jul 16, 2026 | BUY |
Strong Buy
+178.0% avg upside
19 analysts
|
$8.00
129.22% Upside
|
-40.2% | · |
|
STLN
Starling Oncology Institute
|
Jul 15, 2026 | BUY |
Strong Buy
+11.2% avg upside
7 analysts
|
$9.00
42.45% Upside
|
+17.7% | · |
|
SLP
Simulations Plus
|
Jun 16, 2026 | HOLD |
Buy
+105.4% avg upside
11 analysts
|
$18.50
0.34% Upside
|
+1.2% | · |
|
DOCS
Doximity
|
May 14, 2026 | HOLD |
Buy
+29.2% avg upside
28 analysts
|
— | +46.3% | · |
|
OMCL
Omnicell
|
Apr 28, 2026 | HOLD |
Strong Buy
+47.4% avg upside
12 analysts
|
— | -26.0% | · |
|
IQV
IQVIA Holdings
|
Feb 05, 2026 | HOLD |
Strong Buy
-7.1% avg upside
39 analysts
|
— | +48.2% | · |
|
PIII
P3 Health Partners
|
Nov 14, 2025 | HOLD |
Buy
+2036.8% avg upside
8 analysts
|
— | +3.1% | · |
|
AGL
Agilon Health
|
Nov 04, 2025 | HOLD |
Buy
-12.8% avg upside
26 analysts
|
— | +336.9% | · |
|
BBLNF
Babylon Holdings
|
Jun 23, 2023 | HOLD |
Buy
+65549900.0% avg upside
6 analysts
|
— | · | · |
|
CRL
Charles River Labs
|
Aug 14, 2019 | HOLD |
Strong Buy
-14.5% avg upside
35 analysts
|
— | +69.5% | · |
|
CVS
CVS Health
|
Aug 14, 2019 | HOLD |
Strong Buy
+25.5% avg upside
39 analysts
|
— | +15.6% | · |
|
COR
Cencora
|
Aug 14, 2019 | HOLD |
Buy
+5.9% avg upside
45 analysts
|
— | +30.1% | · |
|
CAH
Cardinal Health
|
Nov 16, 2018 | HOLD |
Strong Buy
-6.0% avg upside
30 analysts
|
$55.00
75.37% Downside
|
+5.7% | · |
|
ACH
Accendra Health
|
Oct 31, 2018 | HOLD |
Sell
+2950.6% avg upside
17 analysts
|
$9.00
1499.44% Upside
|
-13.7% | · |
|
MCK
McKesson
|
May 29, 2018 | HOLD |
Strong Buy
-11.2% avg upside
29 analysts
|
$160.00
81.28% Downside
|
-10.2% | · |
|
MDRX
Veradigm
|
Jun 19, 2017 | HOLD |
Buy
+191.7% avg upside
22 analysts
|
$13.00
152.83% Upside
|
+2.7% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.